Advancing personalized medicine for patients

PATIENT ENGAGEMENT | MARKETING & COMMUNICATIONS | BRANDING

Recruitment & retention materials for Guardant Health’s research portfolio

Guardant Health is a precision oncology company with a suite of comprehensive genomic profiling products that help physicians make more informed decisions across the care continuum. Its clinical research portfolio is helping transform the way doctors detect and treat cancer and other emerging diseases. Guardant engaged Speaking of Science to develop recruitment materials for its clinical research portfolio, including the landmark ECLIPSE study, a 10,000+ colorectal cancer screening study, and the patient-centric GRECO-Breast study.

PROJECT

Brand Identity
Art Direction
Copywriting
Content Creation
Plain Language Writing
Recruitment & Retention Campaign
Print & Digital Media
Website Design & Development
Style Guidelines

HOW WE HELPED

Guardant-19

ECLIPSE (Evaluation of ctDNA LUNAR Assay In an Average Patient Screening Encounter)

Guardant360® Related Clinical Outcomes in Patients Who Share Medical Records-Breast Cancer (GRECO-B)

A validation study to build COVID-19 testing capacity

A study to evaluate whether early signs of colorectal cancer can be detected by a simple blood test

A study to evaluate how liquid biopsy impacts treatment selection in breast cancer patients and how well that treatment plan works